Our Approved Medicine | Day One Biopharmaceuticals

Our approved
medicine

Day One is committed to bringing forward targeted therapies designed for children. Supporting kids and families is at the heart of everything we do.

To learn more about OJEMDA^TM (tovorafenib), visit the product website or download prescribing information below.

U.S. Prescribing Information
Patient Information, including Instructions For Use
For U.S. Healthcare Providers: ojemdahcp.com
For Patients and Caregivers: www.ojemda.com

Day One Biopharmaceuticals is dedicated to helping patients access OJEMDA^TM and support their families throughout the treatment journey.

As part of this commitment, we are pleased to announce EveryDay Support From Day One^TM, a comprehensive program that offers personalized services for OJEMDA^TM patients and their care teams, including insurance coverage support, financial assistance options, shipping medication to patients’ homes, and educational resources throughout the treatment journey.

Caregivers and healthcare providers can
visit www.everydaysupport.com or call a Patient Navigator at 855-DAY1-BIO (855‑329‑1246) for more information.

Visit everydaysupport.com

TOVO-US-0352, 12/24 V1